Abstract
447. Reduction of Sensory Reactivity Symptoms Corresponds to Improved Psychiatric Symptoms in an Open-Label Study of Low-Dose Ketamine in Children With ADNP Syndrome
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have